1.86
5.61%
-0.10
Schlusskurs vom Vortag:
$1.96
Offen:
$1.93
24-Stunden-Volumen:
90,157
Relative Volume:
0.80
Marktkapitalisierung:
$270.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-8.2777
EPS:
-0.2247
Netto-Cashflow:
-
1W Leistung:
-11.48%
1M Leistung:
-4.39%
6M Leistung:
-42.72%
1J Leistung:
-0.80%
Immutep Limited Adr Stock (IMMP) Company Profile
Firmenname
Immutep Limited Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IMMP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
IMMP | 1.86 | 270.75M | 0 | 0 | 0 | -0.2247 |
VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 748.00 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 590.18 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.61 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 107.08 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2021-08-03 | Eingeleitet | Ladenburg Thalmann | Buy |
2021-07-16 | Fortgesetzt | Maxim Group | Buy |
2018-09-28 | Eingeleitet | B. Riley FBR | Buy |
2018-02-15 | Bestätigt | Maxim Group | Buy |
Immutep Limited Adr Aktie (IMMP) Neueste Nachrichten
Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - The Manila Times
Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewswire Inc.
Immutep Limited ADR (IMMP) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Metric Deep Dive: Understanding Immutep Limited ADR (IMMP) Through its Ratios - The Dwinnex
Immutep reports positive results in cancer study - Investing.com
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September - Benzinga
Research Analysts Issue Forecasts for Immutep Limited’s FY2025 Earnings (NASDAQ:IMMP) - Defense World
Immutep Limited ADR (IMMP) Stock: Navigating a Year of Volatility - The InvestChronicle
Short Interest in Immutep Limited (NASDAQ:IMMP) Declines By 10.1% - Defense World
Immutep Announces First Participant Dosed in Phase I Study of IMP761, a First in Class Agonist LAG-3 Antibody - GlobeNewswire
Virtu Financial LLC Buys 32,864 Shares of Immutep Limited (NASDAQ:IMMP) - Defense World
Immutep reports steady progress in Q4 FY24 - Investing.com India
Immutep reports steady progress in Q4 FY24 By Investing.com - Investing.com Australia
Immutep Limited (NASDAQ:IMMP) Shares Acquired by BNP Paribas Financial Markets - Defense World
Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer - GlobeNewswire
Guess which ASX healthcare stock is surging on big FDA news - The Motley Fool
Why 29Metals, Immutep, Insignia, and Perenti shares are pushing higher today - The Motley Fool
FY2027 EPS Estimates for Immutep Limited (NASDAQ:IMMP) Cut by Capital One Financial - American Banking and Market News
Equities Analysts Set Expectations for Immutep Limited’s FY2029 Earnings (NASDAQ:IMMP) - Defense World
Immutep Limited (NASDAQ:IMMP) Short Interest Up 6.2% in June - Defense World
Immutep Receives Regulatory Clearance for Phase I Study of - GlobeNewswire
Get in on Immutep Limited ADR’s (IMMP) buy-in window today! - SETE News
Immutep Limited ADR: Weathering Stock Market Storms with 257.67M Market Cap - The InvestChronicle
Examining IMMP’s book value per share for the latest quarter - US Post News
Immutep (IMMP) Up as Combo Therapy Meets Carcinoma Study Goals - Zacks Investment Research
Immutep Limited ADR Inc. (IMMP) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Why Is Australia Based Immutep's Stock Soaring On Friday?Immutep (NASDAQ:IMMP) - Benzinga
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Why Immutep, Kingsgate, Netwealth, and Ora Banda shares are storming higher - The Motley Fool
Why is this ASX healthcare stock rocketing 25% on Friday? - The Motley Fool
Immutep Reports Positive Results in First Line Head and - GlobeNewswire Inc.
Balance Sheet Breakdown: Immutep Limited ADR (IMMP)'s Debt-to-Equity and Long-Term Debt/Eq Ratios – DWinneX - The Dwinnex
Immutep Limited (NASDAQ:IMMP) Short Interest Up 6.6% in June - Defense World
Holdings of Immutep Limited ADR (IMMP) are aligned with the stars – Sete News - SETE News
Market cap of Blue Star Foods Corp [BSFC] reaches 2.18M – now what? – The DBT News - The DBT News
Guggenheim lifts Invivyd Inc [IVVD] price estimate. Who else is bullish? – The DBT News - The DBT News
Chegg Inc [CHGG] stock Downgrade by Jefferies analyst, price target now $4 – The DBT News - The DBT News
Immutep Limited ADR (IMMP) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
IMMP's price-to-book ratio: An indicator of the company's performance – US Post News - US Post News
Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com
Immutep licenses new anti-cancer molecules from Cardiff University - Investing.com India
Short Interest in Immutep Limited (NASDAQ:IMMP) Increases By 5.1% - Defense World
Immutep Limited ADR Inc. (IMMP) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Immutep Limited ADR (IMMP) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Quarterly Snapshot: Quick and Current Ratios for Immutep Limited ADR (IMMP) – DWinneX - The Dwinnex
Immutep slips after stock offering - MSN
Immutep stock slips after share offering (NASDAQ:IMMP) - Seeking Alpha
Stocks of the Hour: Immutep, INOVIQ, Eastern Metals - Finance News Network
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial - GlobeNewswire
Financial Fitness Check: Examining Immutep Limited ADR (IMMP)'s Key Ratios – DWinneX - The Dwinnex
Immutep Limited (NASDAQ:IMMP) Short Interest Update - Defense World
Finanzdaten der Immutep Limited Adr-Aktie (IMMP)
Es liegen keine Finanzdaten für Immutep Limited Adr (IMMP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):